How to Verify a Compounding Pharmacy Before Buying GLP-1s Online

The Two-Minute Answer

To verify a compounding pharmacy before buying GLP-1 medication online, confirm four things: the telehealth company publicly names the pharmacy that will fill your prescription; that pharmacy holds an active license with its state board of pharmacy, checkable for free through the board's online license search (for example, VialsRx holds Texas State Board of Pharmacy license #35264); the pharmacy operates as a 503A compounding pharmacy with sterile-compounding capability; and its license record shows no unresolved disciplinary actions. A seller that hides its pharmacy, markets GLP-1s as research chemicals, or skips the prescription requirement fails the test automatically, regardless of how professional its website looks.

That is the whole framework. The rest of this guide walks through each step using a real pharmacy and a real license number as the worked example. None of the checks require an account, a payment, or a phone call; every one uses public government records.

The stakes justify the ten minutes. The National Association of Boards of Pharmacy reports that nearly 95 percent of the tens of thousands of online drug sellers it has reviewed operate out of compliance with state and federal pharmacy laws and patient-safety standards. The compounded GLP-1 market sits directly in the path of that problem, and verification is the one tool a consumer has that works.

Why Pharmacy Verification Exists at All

The modern rulebook for compounding pharmacies was written in response to a catastrophe. According to the Centers for Disease Control and Prevention, the 2012 fungal meningitis outbreak traced to contaminated injections from the New England Compounding Center sickened 753 people and killed 64 across 20 states, the deadliest compounding failure in United States history. Congress responded with the Drug Quality and Security Act of 2013, which clarified the two-tier system that still governs compounding today: traditional 503A pharmacies serving individual patients under state oversight, and larger 503B outsourcing facilities registered directly with the FDA.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a compounding pharmacy may prepare a medication only pursuant to a valid prescription for a specific patient, must be licensed by its state board of pharmacy, and must follow applicable United States Pharmacopeia standards, including USP Chapter 797 for sterile preparations such as the injectable GLP-1s. In exchange, 503A preparations are exempt from FDA new-drug approval. That is why compounded semaglutide, which contains the active ingredient in Wegovy and is prepared per individual prescription by a state-licensed 503A pharmacy, is not itself FDA-approved as a drug even when lawfully prepared.

The practical consequence: the license is the safety system. State boards inspect facilities, enforce sterile-compounding standards, and publish disciplinary records; a seller outside that system is accountable to no one. Our review of the 2026 federal compounding rules covers the regulatory layer, and our guide to whether compounded semaglutide is safe covers the clinical layer. This article covers the part only you can do: checking the license.

Step 1: Run the State License Lookup (Worked Example)

Every state board of pharmacy in the United States operates a free, public license-verification search. Here is the check performed on a real pharmacy, VialsRx, using the Texas State Board of Pharmacy lookup:

If the pharmacy is licensed in another state, the process is identical: find that board's search tool through the National Association of Boards of Pharmacy directory and run the same four checks.

Steps 2 and 3: Confirm 503A Status and Check Discipline

Confirm the regulatory category. Ask, or check the provider's published materials for, a plain statement that the pharmacy operates under Section 503A. The category matters because it defines the rules the pharmacy must follow: patient-specific prescriptions only, state licensure and inspection, and USP-compliant compounding. If a seller cannot say whether its source is a 503A pharmacy or a 503B outsourcing facility, it usually means there is no licensed source at all. For injectables, also confirm sterile-compounding capability specifically; a license to compound non-sterile creams and capsules does not authorize sterile injectable work under USP Chapter 797.

Then check the record in two more places. First, the state board's disciplinary listings from Step 1: read what any order actually says, since a paperwork citation from a decade ago is very different from a recent sterility violation. Second, the FDA's public database of warning letters and compounding inspection observations, searchable by firm name at fda.gov. A pharmacy with an active license, a clean record in both databases, and a telehealth partner that names it publicly has passed the strongest screen available to a consumer.

Red Flags That End the Conversation

Some signals no legitimate operation ever exhibits. Any one of these should end the transaction.

No named pharmacy. A telehealth company that will not tell you which pharmacy fills your prescription has made verification impossible by design. The pharmacy name and license are public records; legitimate providers treat them as trust signals, not secrets.

Research-chemical framing. Sellers offering semaglutide or tirzepatide labeled for research use only or not for human consumption are not pharmacies. Those phrases are a legal disguise for unregulated vials with no pharmacist, no inspection, and no recourse, and the FDA has repeatedly warned consumers about unapproved GLP-1 products sold outside the prescription system.

No prescription required. Semaglutide and tirzepatide are prescription drugs. Federal law permits a 503A pharmacy to compound them only against a patient-specific prescription, so a no-prescription seller is by definition operating outside the licensed system.

Prices far below the legitimate floor. Provider-supervised compounded GLP-1 programs from licensed sources generally run from roughly $99 to $250 per month, a floor set by the real costs of provider evaluations, sterile compounding, and cold-chain shipping. An offer dramatically below that floor, such as a $40 vial with no provider visit, is priced by skipping those safeguards. Our survey of the cheapest legal GLP-1 options online shows what legitimate pricing looks like across the market.

No license match. If the named pharmacy cannot be found in any state board database, or the record does not match the published license number, treat the name as fictional. Running the Step 1 lookup is precisely how this flag gets caught.

The Provider-Transparency Test

All of the checks above compress into one question you can ask before reading anything else on a telehealth site: does this company name its compounding pharmacies publicly, with license details a stranger can verify? Transparency is costly to fake, because a published license number invites exactly the scrutiny this guide describes. Companies with legitimate pharmacy partners publish the names; companies without them write around the question.

Trimi passes its own test, which is why it can serve as the worked example. Trimi names both partner pharmacies: VialsRx, the primary pharmacy, holding Texas State Board of Pharmacy license #35264, and GreenwichRx. Both are state-licensed 503A compounding pharmacies that prepare compounded semaglutide and compounded tirzepatide per individual prescription after an evaluation by a licensed provider; the compounded preparations are not themselves FDA-approved as drugs. The full clinical process is documented on our how it works page, our roundup of the best compounded GLP-1 providers applies this same transparency standard across the field, and buyers weighing the brand-name route can start with our LillyDirect Zepbound guide.

Whatever provider you choose, run the lookup first. It is free, it is fast, and it is the single highest-value step a GLP-1 buyer can take online.

The Checklist, In One Place

Frequently Asked Questions